Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Non-Muscle Invasive Bladder Cancer. Show all posts
Showing posts with label Non-Muscle Invasive Bladder Cancer. Show all posts
Friday, January 2, 2026

FDA Approves Inlexzo (gemcitabine intravesical system) for the Treatment of Non-Muscle Invasive Bladder Cancer

›
In continuation of my update on  gemcitabine  Johnson & Johnson (NYSE:JNJ) announced  the U.S. Food and Drug Administration (FDA) approv...
Thursday, July 24, 2025

FDA Approves Zusduri (mitomycin) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

›
UroGen Pharma Ltd. announced the U.S. Food and Drug Administration (FDA) approval of  Zusduri, the first and only FDA-approved medication fo...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.